Edition:
United Kingdom

Assertio Therapeutics Inc (ASRT.OQ)

ASRT.OQ on NASDAQ Stock Exchange Global Select Market

5.71USD
22 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.71
Open
$5.73
Day's High
$5.81
Day's Low
$5.60
Volume
112,192
Avg. Vol
282,398
52-wk High
$9.48
52-wk Low
$4.32

Chart for

About

Assertio Therapeutics, Inc. is a specialty pharmaceutical company. The Company focuses on pain and other central nervous system (CNS) conditions. Its products include NUCYNTA ER (tapentadol extended release tablets), NUCYNTA IR (NUCYNTA) (tapentadol), Gralise (gabapentin), Cambia (diclofenac potassium for oral solution),... (more)

Overall

Beta: 1.19
Market Cap(Mil.): $369.12
Shares Outstanding(Mil.): 62.99
Dividend: --
Yield (%): --

Financials

  ASRT.OQ Industry Sector
P/E (TTM): -- 30.90 33.64
EPS (TTM): -1.79 -- --
ROI: -12.06 14.75 14.27
ROE: -43.53 16.24 15.99

Earnings vs. Estimates